Poland - Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale
Since 2014, Poland Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale decreased by 1.1% year on year. With €142,757,293.7 in 2019, the country was ranked number 3 comparing other countries in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale. Poland is overtaken by United Kingdom, which was ranked number 2 at €195,933,082.68 and is followed by Hungary at €128,523,052.44. Germany topped the ranking with €2,350,575,277.14 in 2019, -3.4% versus 2018. Estonia recorded the best 5 years average growth at +11.1% per year, while Netherlands witnessed the worst performance at -38.7% per year.
Loading...
Date | Euros |
---|---|
2019 | 142,757,293.70 |
2018 | 126,345,864.00 |
2017 | 145,531,665.00 |
2016 | 191,176,705.00 |
2015 | 180,721,326.00 |
Download all data from 2002 to 2019
How does Poland rank in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale?
# | 17 Countries | Euros | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
Germany
|
2,350,575,277.14 | 2019 | -3.4 % | +8.0 % | View data |
2 |
#2
United Kingdom
|
195,933,082.68 | 2019 | +2.5 % | -5.9 % | View data |
3 |
#3
Poland
|
142,757,293.70 | 2019 | +13.0 % | -1.1 % | View data |
4 |
#4
Hungary
|
128,523,052.44 | 2019 | +6.3 % | -2.7 % | View data |
5 |
#5
France
|
102,455,978.25 | 2019 | -18.9 % | -0.0 % | View data |